The activated SFTPA2 not only can help signaling transduction in EGFR signaling but also can allow cancer cells to clean the pathogens through expressing Surfactant Protein A2 (SFTPA2) to survive in early stage LADC. This evidence concerns the gene SFTPA2 and cancer.